Outlook Therapeutics Incs. (OTLK) PT Raised to $7.50 at Ascendiant Capital
Tweet
Share
E-mailGet Alerts OTLK Hot Sheet
Price: $1.11 -1.77%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
Ascendiant Capital analyst Edward Woo raised the price target on Outlook Therapeutics Incs. (NASDAQ: OTLK) to $7.50 (from $7.25) while maintaining a Buy rating.
You May Also Be Interested In
- Brainsway (BWAY) PT Raised to $20 at BTIG
- JPMorgan Upgrades YTL Power International (YTLP:MK) to Overweight
- Suzuken Co Ltd (9987:JP) PT Lowered to JPY5,570 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
